The co-treatment of pre-osteoclasts with NSCLC-exosomes and AREG neutralizing antibodies reverted the effects of osteoclasts differentiation mediated by NSCLC exosomes (Fig. 7). Here, AREG is linked to non-small cell lung carcinoma.